TNGX - Latest News
Tango Therapeutics, Inc. (TNGX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $4.17B. Beta to the broader market is 1.15.
The article list below shows the most recent TNGX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent TNGX Headlines
Tango Therapeutics: Promising Early Data, But A Long Road Ahead
seekingalpha.com - Aug 16, 2026
Vopimetostat's combination with daraxonrasib has produced an unusually strong early pancreatic-cancer signal, but the evidence still comes from a very
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
zacks.com - Aug 12, 2026
Tango Therapeutics stock falls 5% on a wider-than-expected Q2 loss, reflecting higher operating expenses, while pipeline progress remains in focus.
Tango Therapeutics Announces Executive Chair Transition
globenewswire.com - Aug 6, 2026
BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc.
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
zacks.com - Aug 3, 2026
Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly resul
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Recommendation of “Moderate Buy” by Analysts
defenseworld.net - Aug 3, 2026
Shares of Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen research firms
How News Affects TNGX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TNGX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked TNGX news questions
- What is the latest TNGX news headline?
- The most recent TNGX headline (Aug 16, 2026) is "Tango Therapeutics: Promising Early Data, But A Long Road Ahead". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the TNGX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What TNGX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual TNGX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.